A carregar...
Bevacizumab is safe in acute relapses of neuromyelitis optica
OBJECTIVES: Neuromyelitis optica (NMO) is a relapsing autoimmune disease targeting the spinal cord and optic nerve leading to paralysis and blindness. Current treatment for acute NMO attacks is immunosuppression with high-dose corticosteroids and/or plasmapheresis. Preclinical animal studies suggest...
Na minha lista:
| Publicado no: | Clin Exp Neuroimmunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4729701/ https://ncbi.nlm.nih.gov/pubmed/26834844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen3.12239 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|